Insulin Product definition

Insulin Product means [***].
Sample 1Sample 2Sample 3
Insulin Product means any Product comprised of insulin and/or its derivatives and analogs or any precursor of any of the following (in particular human insulin or animal insulin) including, without limitation, any (or any combination) of the following: (1) natural insulins; (2) chemically synthesized insulins; (3) insulin analogs, including, by way of example, analogs of human or animal insulin which are distinguished from natural insulin by a combination of a substitution or addition of at least one natural or non-natural amino acid residue and/or deletion of at least one amino acid residue in comparison to the natural insulin: and (4) insulin derivatives, including, by way of example, derivatives of a natural insulin or insulin analogs obtained by chemical modification of the respective natural insulin or insulin analog.
Sample 1
Insulin Product means the insulin product described as a JV Product in Schedule 1 (sometimes referred to as “NP-I PharmFilm”) and any and all analogs, derivatives, or pro-drugs of such insulin product incorporating the IP of both Parties.
Sample 1

Examples of Insulin Product in a sentence

  • In clinical studies of our flagship oral insulin product Generex Oral-lyn™, insulin absorption in the buccal cavity has been shown to be efficacious and safe.Buccal Insulin Product – Generex Oral-Lyn™ Insulin is a hormone that is naturally secreted by the pancreas to regulate the level of glucose, a type of sugar, in the bloodstream.

  • When a Covered Insulin Product does not qualify as preventive care, the cost share cap shall not apply until deductible has been met.Not coveredPrescription drug benefits are subject to the following terms and conditions:• To be eligible for benefits, drugs must be FDA-approved legend drugs prescribed by a physician and dispensed by a licensed pharmacist.

  • Arlene Weintraub, Merck Ditches Biosimilar Lantus, But Will That Ease the Path for Mylan’s Rival Insulin Product?, FiercePharma (Oct.

  • Includes an electric fold-in function for getting into tight spaces.

  • PDE Field Example #5: Covered Insulin Product in the Coverage Gap Phase of an EA PlanThis example demonstrates how to report a PDE for a $575.00 covered insulin product ($568.00 ingredient cost/$7.00 dispensing fee) that falls within the Coverage Gap Phase of an EA plan.Step 1 – Determine costs that fall within the Coverage Gap:When the claim adjudication begins, the TGCDC Accumulator is $6,830.00 and the TrOOP Accumulator is $1,235.00.

  • Decision Guidance: Choosing an Insulin Product This brief review of the evidence surrounding insulinanalogues can be used to helpsupport decision around insulin choice.

  • When a Covered Insulin Product does not qualify as preventive care, the cost share cap shall not apply until deductible has beenmet.Not coveredExtended Supply Network Benefits‌ SERVICE OR SUPPLYIN-NETWORK PLAN PAYSOUT-OF-NETWORK PLAN PAYSExtended Supply Network ProgramThe extended supply network for the plan is the PreferredONE ESN Network.

  • In July 2021, the FDA approved the first interchangeable insulin product, Semglee, which is both biosimilar to and interchangeable with its reference product, Lantus (insulin glargine).Source: U.S. Food and Drug Administration (FDA), “FDA Approves First Interchangeable Biosimilar Insulin Product for Treatment of Diabetes,” press release, July 28, 2021, at https://www.fda.gov/news-events/press- announcements/fda-approves-first-interchangeable-biosimilar-insulin-product-treatment-diabetes.

  • See also FDA, “FDA Approves First Interchangeable Biosimilar Insulin Product for Treatment of Diabetes,” July 28, 2021.

  • The class definition also clarifies: “For the avoidance of doubt, if a Person purchased a Lilly Insulin Product on at least one occasion at a price calculated by reference to a list price, AWP, and/or WAC, as defined in this paragraph, that Person shall be a Settlement Class Member, even if on another occasion that Person purchased or received a Lilly Insulin Product that was not paid at a price calculated by reference to a list price, AWP, and/or WAC.

Related to Insulin Product

  • Licensed Product means a product, method or service in the Licensed Field of Use, the making, having made, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent.

  • Cannabis product means cannabis that has undergone a process whereby the plant material has been transformed into a concentrate, including, but not limited to, concentrated cannabis, or an edible or topical product containing cannabis or concentrated cannabis and other ingredients.

  • complex product means a product which is composed of multiple components which can be replaced permitting disassembly and re-assembly of the product.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Generic Product means any pharmaceutical product that (i) is sold by a Third Party that is not an Affiliate or licensee of Buyer and (ii) (a) contains the same active pharmaceutical ingredient as the Product or (b) is categorized by the applicable Governmental Entity in a country to be therapeutically equivalent to, or interchangeable with, the Product, such that the pharmaceutical product may be substituted for the Product at the point of dispensing without any intervention by the prescribing physician in such country.

  • Spray buff product means a product designed to restore a worn floor finish in conjunction with a floor buffing machine and special pad.

  • Product means any deliverable under the Contract, which may include commodities, services, technology or software.

  • Combination Product means any product that comprises a Licensed Compound or Licensed Product sold in conjunction with another active component so as to be a combination product (whether packaged together or in the same therapeutic formulation).

  • Biosimilar Product means, with respect to a Licensed Product in any country, any biosimilar product sold by a Third Party not authorized by or on behalf of Celgene, its Affiliates or Sublicensees, (a) that is a biosimilar biological product, as defined in 21 USC 379j-51 (or any successor or replacement thereof), a similar biological medicinal product, as defined in Annex I to Directive 2001/83/EC (or any successor or replacement thereof), or any similar biosimilar or generic product under the Laws of any country or jurisdiction, or (b) regarding which Regulatory Approval is obtained by referencing Regulatory Data of such Licensed Product.

  • Tobacco product means any substance containing tobacco leaf, including but not limited to, cigarettes, cigars, pipe tobacco, hookah tobacco, snuff, chewing tobacco, dipping tobacco, bidis, blunts, clove cigarettes, or any other preparation of tobacco; and any product or formulation of matter containing biologically active amounts of nicotine that is manufactured, sold, offered for sale, or otherwise distributed with the expectation that the product or matter will be introduced into the human body by inhalation; but does not include any cessation product specifically approved by the U.S. Food and Drug Administration for use in treating nicotine or tobacco dependence.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Nicotine product means a product that contains nicotine and is not any of the following:

  • Other Product means Product which an End User acquired from sources other than Integrator.

  • Vapor product means any:

  • Aerosol coating product means a pressurized coating product containing pigments or resins that dispenses product ingredients by means of a propellant, and is packaged in a disposable can for hand-held application, or for use in specialized equipment for ground traffic/marking applications.

  • Cannabis products means cannabis that has undergone a process whereby the plant material has been transformed into a concentrate, including, but not limited to, concentrated cannabis, or an edible or topical product containing cannabis or concentrated cannabis and other ingredients.

  • Licensed Products means tangible materials which, in the course of manufacture, use, sale, or importation, would be within the scope of one or more claims of the Licensed Patent Rights that have not been held unpatentable, invalid or unenforceable by an unappealed or unappealable judgment of a court of competent jurisdiction.

  • Marihuana-infused product means a topical formulation, tincture, beverage, edible substance, or similar product containing marihuana and other ingredients and that is intended for human consumption.

  • Combination Products means any product containing both a pharmaceutically active agent or ingredient which constitutes a Licensed Product and one or more other pharmaceutically active agents or ingredients which do not constitute Licensed Products.

  • Bundled Product means Product sold together with any other product(s) or service(s) at a single unit price, whether packaged together or separately, and which other product(s) or service(s) have material independent value from Product itself.

  • Licensed Compound means [***].

  • Aerosol product means a pressurized spray system that dispenses product ingredients by means of a propellant contained in a product or a product's container, or by means of a mechanically induced force. “Aerosol Product” does not include “Pump Spray.”

  • Licensed producer means a person or entity licensed to produce medical cannabis.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Drug Product means a specific drug in dosage form from a known source of manufacture, whether

  • medicinal product means any substance or combination of substances presented for treating or preventing disease in human beings or animals and any substance or combination of substances which may be administered to human beings or animals with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions in humans or in animals;